STOCK TITAN
  1. Home
  2. Sec-filings
  3. VNRX
  4. [EFFECT] VolitionRX Limited SEC Filing

[EFFECT] VolitionRX Limited SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 14, 2025 5:00 P.M.
Form: S-3
CIK: 0000093314
Company Name: VOLITIONRX LTD
File Number: 333-288508

Source: View Original Filing on SEC EDGAR

Stock VNRX logo
Volitionrx

NYSE:VNRX

VNRX Rankings

#5008 Ranked by Market Cap
N/A Ranked by Dividends

VNRX Latest News

Aug 14, 2025
VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update
Aug 8, 2025
VolitionRx Limited Schedules Second Quarter 2025 Earnings Conference Call and Business Update
Aug 4, 2025
VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering
Jul 16, 2025
Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation
Jul 8, 2025
Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes

VNRX Latest SEC Filings

Aug 19, 2025
[Form 4] VolitionRX Limited Insider Trading Activity
Aug 19, 2025
[Form 4] VolitionRX Limited Insider Trading Activity
Aug 19, 2025
[Form 4] VolitionRX Limited Insider Trading Activity
Aug 19, 2025
[Form 4] VolitionRX Limited Insider Trading Activity
Aug 19, 2025
[Form 4] VolitionRX Limited Insider Trading Activity

VNRX Stock Data

71.68M
86.71M
17.84%
22.29%
0.18%
Medical Devices
In Vitro & in Vivo Diagnostic Substances
Link
United States
HENDERSON